Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resistant Cancer”

3,681 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,681 results

Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Testing effectiveness (Phase 2)Study completedNCT03227926
What this trial is testing

Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance

Who this might be right for
Colorectal Cancer
Fondazione del Piemonte per l'Oncologia 32
Testing effectiveness (Phase 2)Study completedNCT00044538
What this trial is testing

Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bayer 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT04258943
What this trial is testing

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

Who this might be right for
Philadelphia Chromosome Positive CMLAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous Leukemia+1 more
Children's Oncology Group 60
Not applicableLooking for participantsNCT07609485
What this trial is testing

Identifying Cellular and Molecular Determinants of Efficacy and Resistance in Patients Undergoing CAR-T Therapy

Who this might be right for
CancerHematologic Malignancy
University Hospital, Lille 700
Not applicableStudy completedNCT02451215
What this trial is testing

Laser Interstitial Thermal Therapy (LITT) for the Treatment of Pediatric Central Nervous System Tumors

Who this might be right for
Brain Tumor
Children's Hospitals and Clinics of Minnesota 10
Post-approval studies (Phase 4)Study completedNCT00727961
What this trial is testing

Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)

Who this might be right for
Ovarian Neoplasms
Merck Sharp & Dohme LLC 58
Not applicableStudy completedNCT03490747
What this trial is testing

Evaluation of a Physical Activity Referral Scheme

Who this might be right for
Cardiovascular Risk FactorDiabetes Mellitus, Type 2Anxiety+7 more
Paula Watson 68
Not applicableLooking for participantsNCT06551285
What this trial is testing

Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.

Who this might be right for
Polycystic Ovary SyndromeMetabolic Syndrome
Celia Bañuls 120
Testing effectiveness (Phase 2)UnknownNCT00021385
What this trial is testing

Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer

Who this might be right for
Ovarian Cancer
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT06751485
What this trial is testing

JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary PeritonealFallopian Tube Cancers
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 430
Not applicableStudy completedNCT01068210
What this trial is testing

Lung Cancer Exercise Training Study

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 110
Testing effectiveness (Phase 2)WithdrawnNCT02965417
What this trial is testing

Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients

Who this might be right for
Metastatic Colorectal Cancer
Symphogen A/S
Not applicableStudy completedNCT01025518
What this trial is testing

DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients

Who this might be right for
Head and Neck Neoplasms
Danish Head and Neck Cancer Group 30
Not applicableStudy completedNCT03575260
What this trial is testing

500mg Fulvestrant Versus Exemestane in MBC

Who this might be right for
Breast Cancer
Fudan University 120
Testing effectiveness (Phase 2)Study completedNCT07635082
What this trial is testing

Extended Letrozole Protocol Versus Letrozole Plus Inositol for Induction of Ovulation in Letrozole Resistant PCOS Women

Who this might be right for
Polycystic Ovary Syndrome (PCOS) WomenPolycystic Ovary Syndrome
Eman Basuni Ebrahim Mowad 200
Testing effectiveness (Phase 2)WithdrawnNCT06545617
What this trial is testing

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

Who this might be right for
Platinum-resistant Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Bio-Thera Solutions
Not applicableTemporarily pausedNCT03236688
What this trial is testing

Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer
Exosome Diagnostics, Inc. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02893917
What this trial is testing

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Adenocarcinoma With Neuroendocrine DifferentiationCastration-Resistant Prostate CarcinomaMetastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623460
What this trial is testing

Zanzalintinib Efficacy Post Pluvicto® in Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer

Who this might be right for
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Stuthi Perimbeti 30
Load More Results
90